#USA #Everest Group #Conshohocken #Suvoda IRT #RTSM technology

Suvoda IRT Recognized as a Leading Force in the RTSM Technology Sphere

Suvoda, a prominent player in the clinical trial technology sector, has achieved a significant milestone by being named a Leader in the Everest Group's PEAK Matrix® assessment for Randomization and Trial Supply Management (RTSM) technology. This recognition validates the company's commitment to innovation and excellence within the competitive landscape of clinical trial management.

The Everest Group's PEAK Matrix® serves as a comprehensive evaluation framework, incorporating data-driven analysis of technology providers while assessing their market impact, vision, and delivery capabilities. What sets this evaluation apart is the inclusion of direct customer feedback, which provides insights into actual performance and user experience. This combination of rigorous assessment methods illustrates Suvoda's robust market presence and technological advancements in the RTSM domain.

According to Nisarg Shah, Practice Director at Everest Group, "Suvoda exemplifies specialization in managing complex, multi-arm studies. Their use of a low-code/no-code platform, alongside the innovative Virtual Partition framework and extensive integration network, positions them favorably within the industry. Furthermore, their modular architecture, flexibility in study configurations, and investment in AI-driven automation have rightfully earned them the distinguished Leader position in our latest assessment."

The recognition from Everest Group comes as a testament to Suvoda's dedication to enhancing the clinical trial experience. The company recognizes the challenges faced by sponsors, Clinical Research Organizations (CROs), and clinical trial sites, striving to offer solutions that simplify the complexities involved in executing clinical trials.

Jagath Wanninayake, CEO of Suvoda, expressed pride in the acknowledgment: "Being named a Leader by Everest Group reinforces our belief that Suvoda IRT provides unmatched capabilities and speed for randomization and supply management in intricate clinical trials. It also highlights our ongoing efforts to refine our platform by integrating IRT with our comprehensive suite of offerings, enabling us to manage critical and time-sensitive phases of each study more effectively."

Suvoda IRT functions as a central hub for clinical trial logistics. It empowers sponsors, CROs, and sites to ensure that each treatment is administered to the correct patient at precisely the right moment. Underpinned by a customizable architecture, Suvoda IRT can adeptly manage even the most intricate trial protocols while offering real-time inventory tracking and predictive resupply capabilities. The system is designed to adapt promptly to modifications in study objectives through embedded customization tools available within the Suvoda Platform. This innovation is further fortified by a range of issued patents awarded to the company for their unique contributions to the field.

To elevate usability and improve operational efficiency, Suvoda has recently introduced an AI assistant, named Sofia. This advanced tool simplifies the responsibilities of drug supply managers by including features such as monitoring inventory levels, reviewing visit schedules, and generating data visualizations—all through a conversational interface. Moreover, Sofia provides real-time analytic capabilities with both preset and ad-hoc reports, equipping teams with the insights necessary for informed decision-making.

This latest recognition solidifies Suvoda's position as a trailblazer in transforming the clinical trial journey for sponsors, CROs, and patients alike, making the overall experience more streamlined and intuitive. The results of the Everest Group report on Suvoda IRT are available for those who wish to gain deeper insights into this industry-leading platform.

About Suvoda

Suvoda stands as a global leader in clinical trial technology, offering a real-time experience platform that enables sponsors and CROs to make thoughtful decisions while allowing trial sites and patients to act with clarity and purpose. The company delivers interconnected, action-oriented software solutions complemented by top-tier services and support to ensure that even during the most urgent phases, life changing clinical studies keep advancing. Suvoda's recent merger with Greenphire, a leader in clinical trial financial management, further amplifies its capabilities to serve the industry more effectively. For more details about their offerings, visit suvoda.com and connect with Suvoda on LinkedIn.